AB Corporate Bond ETF (EYEG) Stock Price, News & Analysis
Company Description
AB Corporate Bond ETF (NASDAQ: EYEG) is classified in the Pharmaceutical Preparations sector.
EYEG has declined 2.5% over the past year. Shares last traded at $34.73.
This page collects what Stock Titan holds for EYEG, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AB Corporate Bond ETF (EYEG) stock last closed at $34.73. Over the past 12 months, the stock has lost 2.5%.
Latest News
AB Corporate Bond ETF has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management, acquisition, conferences, clinical trial, earnings. View all EYEG news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in AB Corporate Bond ETF (EYEG) currently stands at 98 shares, down 1.0% from the previous reporting period, representing 0.0% of the shares outstanding. Since July 2025, short interest has decreased by 92.7%.
Days to Cover History
Days to cover for AB Corporate Bond ETF (EYEG) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 95.2% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 20.8 days.
EYEG Company Profile & Sector Positioning
AB Corporate Bond ETF (EYEG) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.